Showing results (401-410 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|June 5, 2024
Phospholipid metabolism-related genotypes of PLA2R1 and CERS4 contribute to nonobese MASLDCongxiang Shao, Junzhao Ye, Zhi Dong, et al.
Hepatology Communications|June 5, 2024
Autoimmune hepatitis: Current and future therapiesNancy S Reau, Craig S Lammert, Ethan M Weinberg
Hepatology Communications|June 6, 2024
BTLA deficiency promotes HSC activation and protects against hepatic ischemia-reperfusion injuryXiaoyun Shen, Rongyun Mai, Xiao Han, et al.
Hepatology Communications|April 26, 2024
Vascular adhesion protein-1 blockade in primary sclerosing cholangitis: Open-label, multicenter, single-arm, phase II trialGideon M Hirschfield, Katherine Arndtz, Amanda Kirkham, et al.
Hepatology Communications|May 2, 2024
An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLDLinqiang Zhang, Yongqiong Shi, Bin Liang, et al.
Hepatology Communications|May 3, 2024
Home exercise, branched-chain amino acids, and probiotics improve frailty in cirrhosis: A randomized clinical trialEva Román, Naujot Kaür, Elisabet Sánchez, et al.
Hepatology Communications|May 2, 2024
Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCCLauriane Blukacz, Sandro Nuciforo, Geoffrey Fucile, et al.
Hepatology Communications|May 3, 2024
PHES scores have limited impact on the risk of overt HE in patients with minimal HESimon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, et al.
Hepatology Communications|May 2, 2024
Surveillance MRI is associated with improved survival in patients with primary sclerosing cholangitisNatassia Tan, Natalie Ngu, Thomas Worland, et al.
Hepatology Communications|November 8, 2023
Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studiesTeerha Piratvisuth, Jinlin Hou, Tawesak Tanwandee, et al.
Pageof 179